These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10643854)

  • 1. Update on mycophenolate mofetil.
    Goldstein SL
    Pediatr Infect Dis J; 2000 Jan; 19(1):73-5. PubMed ID: 10643854
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.
    Smak Gregoor PJ; van Gelder T; Weimar W
    Neth J Med; 2000 Dec; 57(6):233-46. PubMed ID: 11099793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
    Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Mar; 30(2):507-8. PubMed ID: 9532150
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; West M; Gruessner AC
    Transplant Proc; 1998 Mar; 30(2):518-20. PubMed ID: 9532156
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined immunosuppression with cyclosporine, rapamycin, and mycophenolate mofetil controls rejection with minimal nutritional impact in experimental small intestinal transplantation.
    Sigalet DL; Thorne PC; Martin GR; Garola RE; Yatscoff RW
    Transplant Proc; 2002 Jun; 34(4):1121-3. PubMed ID: 12072293
    [No Abstract]   [Full Text] [Related]  

  • 10. First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation.
    Kahl A; Bechstein WO; Platz K; Müller A; Berweck S; Venz S; Neuhaus P; Frei U
    Transplant Proc; 1998 Mar; 30(2):505-6. PubMed ID: 9532149
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: possible risks and benefits.
    Meier-Kriesche HU
    Curr Opin Nephrol Hypertens; 2006 Jun; 15 Suppl 1():S1-5. PubMed ID: 16829733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Rinsho; 2005 May; 63 Suppl 5():684-91. PubMed ID: 15954430
    [No Abstract]   [Full Text] [Related]  

  • 13. [The value of mycophenolate mofetil in kidney transplantation. Joint Symposium of the Dutch Society of Nephrology, the German Society of Nephrology and the German Working Group for Clinical Nephrology. Aachen, 8 September 1997].
    Dtsch Med Wochenschr; 1997 Nov; 122(47 Suppl):1-6. PubMed ID: 9431325
    [No Abstract]   [Full Text] [Related]  

  • 14. [Initial experience with mycophenolate mofetil (RS 61443) after kidney transplantation].
    Friedrich J; Erhard J
    Zentralbl Chir; 1994; 119(1):48-9. PubMed ID: 8147160
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil versus sirolimus as an adjunct to calcineurin inhibition after renal transplantation.
    Pavlakis M
    Nat Clin Pract Nephrol; 2006 Oct; 2(10):558-9. PubMed ID: 17003833
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
    Räisänen-Sokolowski A; Myllärniemi M; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation.
    Gritsch HA; Egidi MF; Sugitani A; Jordan ML; Vivas CA; Shapiro R; Scantlebury VP; Randhawa PS; Corry RJ
    Transplant Proc; 1998 Mar; 30(2):526. PubMed ID: 9532161
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study.
    Büsing M; Martin D; Schulz T; Heimes M; Klempnauer J; Kozuschek W
    Transplant Proc; 1998 Mar; 30(2):516-7. PubMed ID: 9532155
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of mycophenolate mofetil (Cellcept) in renal transplantation.
    Vanrenterghem Y
    Contrib Nephrol; 1998; 124():64-9; discussion 69-75. PubMed ID: 9761975
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].
    Uchida K
    Nihon Jinzo Gakkai Shi; 2005; 47(4):423-9. PubMed ID: 15971884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.